Nobutoshi Komatsu

425 total citations
19 papers, 252 citations indexed

About

Nobutoshi Komatsu is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Nobutoshi Komatsu has authored 19 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 12 papers in Hepatology and 4 papers in Rheumatology. Recurrent topics in Nobutoshi Komatsu's work include Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (7 papers). Nobutoshi Komatsu is often cited by papers focused on Liver Disease Diagnosis and Treatment (9 papers), Hepatitis C virus research (9 papers) and Hepatitis B Virus Studies (7 papers). Nobutoshi Komatsu collaborates with scholars based in Japan, France and India. Nobutoshi Komatsu's co-authors include Nobuyuki Enomoto, Taisuke Inoue, Fumitake Amemiya, Shinya Maekawa, Mitsuaki Sato, Yasuhiro Nakayama, Mika Miura, Minoru Sakamoto, Akihisa Tatsumi and Shinichi Takano and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Nobutoshi Komatsu

16 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobutoshi Komatsu Japan 9 201 166 45 34 30 19 252
Zehui Yan China 11 237 1.2× 253 1.5× 64 1.4× 26 0.8× 22 0.7× 18 354
Koju Kobayashi Japan 11 209 1.0× 206 1.2× 85 1.9× 45 1.3× 22 0.7× 22 318
M. Maynard-Muet France 9 220 1.1× 214 1.3× 33 0.7× 15 0.4× 29 1.0× 15 323
Maria Luisa Virata United States 6 272 1.4× 210 1.3× 35 0.8× 80 2.4× 16 0.5× 10 374
Laetitia Zona France 5 105 0.5× 112 0.7× 36 0.8× 36 1.1× 24 0.8× 7 195
Karen Fitzmaurice Ireland 8 281 1.4× 190 1.1× 122 2.7× 43 1.3× 26 0.9× 13 371
Hanna Berak Poland 9 149 0.7× 127 0.8× 30 0.7× 26 0.8× 37 1.2× 41 191
Stefan Zeuzem Germany 6 305 1.5× 292 1.8× 20 0.4× 15 0.4× 32 1.1× 9 360
Alexander McKenzie United States 4 259 1.3× 194 1.2× 73 1.6× 20 0.6× 12 0.4× 5 326
Ralf Dürr Germany 7 180 0.9× 178 1.1× 43 1.0× 53 1.6× 26 0.9× 10 299

Countries citing papers authored by Nobutoshi Komatsu

Since Specialization
Citations

This map shows the geographic impact of Nobutoshi Komatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutoshi Komatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutoshi Komatsu more than expected).

Fields of papers citing papers by Nobutoshi Komatsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobutoshi Komatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutoshi Komatsu. The network helps show where Nobutoshi Komatsu may publish in the future.

Co-authorship network of co-authors of Nobutoshi Komatsu

This figure shows the co-authorship network connecting the top 25 collaborators of Nobutoshi Komatsu. A scholar is included among the top collaborators of Nobutoshi Komatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobutoshi Komatsu. Nobutoshi Komatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Suzuki, Yuichiro, Shinya Maekawa, Nobutoshi Komatsu, et al.. (2019). HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers. PLoS ONE. 14(2). e0212559–e0212559. 8 indexed citations
2.
Shimizu, Tatsuya, Utaroh Motosugi, Nobutoshi Komatsu, et al.. (2019). MRI‐based risk factors of hepatocellular carcinoma in patients with chronic liver disease: A prospective observational study. Journal of Magnetic Resonance Imaging. 51(2). 389–396. 6 indexed citations
3.
Nagata, Yutaka, Kazuhiko NAGASAKA, Mai Murase, et al.. (2017). Successful eradication of Helicobacter pylori with a herbal medicine, goshuyuto (Wu Zhu Yu Tang), plus rabeprazole after failure of triplet therapy with vonoprazan: A report of three cases. Journal of Digestive Diseases. 19(7). 439–442. 4 indexed citations
4.
Sato, Mitsuaki, Shinya Maekawa, Nobutoshi Komatsu, et al.. (2015). Deep Sequencing and Phylogenetic Analysis of Variants Resistant to Interferon-Based Protease Inhibitor Therapy in Chronic Hepatitis Induced by Genotype 1b Hepatitis C Virus. Journal of Virology. 89(11). 6105–6116. 22 indexed citations
5.
Maekawa, Shinya, Nobutoshi Komatsu, Akihisa Tatsumi, et al.. (2015). Semiannual Imaging Surveillance Is Associated with Better Survivalin Patients with Non‐B, Non‐C Hepatocellular Carcinoma. Mediators of Inflammation. 2015(1). 687484–687484. 4 indexed citations
6.
Komatsu, Nobutoshi, Tatsuya Yamaguchi, Hiroshi Hayakawa, et al.. (2014). [Case of leptomeningeal carcinomatosis with esophageal carcinoma presenting with neurological signs].. PubMed. 111(4). 765–72. 1 indexed citations
7.
Miura, Mika, Shinya Maekawa, Mitsuaki Sato, et al.. (2014). Deep sequencing analysis of variants resistant to the non‐structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection. Hepatology Research. 44(14). E360–7. 28 indexed citations
8.
Tatsumi, Akihisa, Shinya Maekawa, Mitsuaki Sato, et al.. (2014). Liver stiffness measurement for risk assessment of hepatocellular carcinoma. Hepatology Research. 45(5). 523–532. 28 indexed citations
9.
Miura, Mika, Shinya Maekawa, Shinichi Takano, et al.. (2013). Deep-Sequencing Analysis of the Association between the Quasispecies Nature of the Hepatitis C Virus Core Region and Disease Progression. Journal of Virology. 87(23). 12541–12551. 31 indexed citations
10.
Maekawa, Shinya, Minoru Sakamoto, Mika Miura, et al.. (2012). Comprehensive analysis for viral elements and interleukin-28B polymorphisms in response to pegylated interferon plus ribavirin therapy in hepatitis C virus 1B infection. Hepatology. 56(5). 1611–1621. 20 indexed citations
11.
Shindo, Hiroko, Shinya Maekawa, M. Miura, et al.. (2012). IL‐28B (IFN‐λ3) and IFN‐α synergistically inhibit HCV replication. Journal of Viral Hepatitis. 20(4). 281–289. 26 indexed citations
13.
14.
Asahina, Yasuhiro, Kaoru Tsuchiya, Mitsuaki Sato, et al.. (2008). Two cases of hepatic angiomyolipoma with different ultrasonographic and radiographic findings. Kanzo. 49(9). 440–448. 1 indexed citations
15.
Kurosaki, Masayuki, Kotaro Matsunaga, Itsuko Hirayama, et al.. (2008). The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy. Journal of Hepatology. 48(5). 736–742. 30 indexed citations
16.
Komatsu, Nobutoshi, Masayuki Kurosaki, Mitsuaki Sato, et al.. (2008). [Epithelioid hemangioendothelioma of the liver diagnosed by laparoscopy guided biopsy].. PubMed. 105(11). 1640–7.
17.
Asahina, Yasuhiro, Namiki Izumi, Itsuko Hirayama, et al.. (2008). Potential Relevance of Cytoplasmic Viral Sensors and Related Regulators Involving Innate Immunity in Antiviral Response. Gastroenterology. 134(5). 1396–1405. 36 indexed citations
18.
Tsuchiya, Kazuhiro, Masahiro Sato, Toshiaki Tanaka, et al.. (2008). 415 ORAL SUPPLEMENTATION WITH BRANCHED-CHAIN AMINO ACIDS (BCAA) IMPROVES SURVIVIAL AND DECREASES THE THIRD TIME RECURRNCE AFTER SUCCESSFUL TREATMENT OF HEPATOCELLULAR CARCINOMA (HCC). Journal of Hepatology. 48. S160–S160. 2 indexed citations
19.
Nagai, Tadashi, Tohru Izumi, Masaaki Takatoku, et al.. (2000). All-trans-retinoic acid treatment for chemotherapy-resistant acute adult T-cell leukemia.. PubMed. 72(3). 343–5. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026